Evidence map›Paper›PMID 31831210›Full record

ArticleThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation2020

T follicular helper and memory cell responses and the mTOR pathway in murine heart transplantation.

Aini Xie, Hui Yan, Jinfei Fu, Adam He, Xiang Xiao, Xian C Li, Wenhao Chen

Open access · greenAbstract read
In one paragraph

Article in The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. METTL3 inhibition reduces NImmunology and cell biology · 2022
    Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Aini XieImmunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute & Institute for Academic Medicine, Houston Methodist Hospital, Houston, Texas; Department of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hui YanImmunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute & Institute for Academic Medicine, Houston Methodist Hospital, Houston, Texas.
Jinfei FuImmunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute & Institute for Academic Medicine, Houston Methodist Hospital, Houston, Texas.
Adam HeImmunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute & Institute for Academic Medicine, Houston Methodist Hospital, Houston, Texas.
Xiang XiaoImmunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute & Institute for Academic Medicine, Houston Methodist Hospital, Houston, Texas.
Xian C LiImmunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute & Institute for Academic Medicine, Houston Methodist Hospital, Houston, Texas; Department of Surgery, Weill Cornell Medicine, Cornell University, New York, New York.
Wenhao ChenImmunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute & Institute for Academic Medicine, Houston Methodist Hospital, Houston, Texas; Department of Surgery, Weill Cornell Medicine, Cornell University, New York, New York. Electronic address: wchen@houstonmethodist.org.
Houston Methodist · US

Funding

IRF4-dependent T-cell effector programs in governing transplant outcomesR01AI132492 · NIAID · METHODIST HOSPITAL RESEARCH INSTITUTE · PI CHEN, WENHAO · 2018 to 2022
$2.0M
NIAID NIH HHS R01 AI132492
6 · The paper itself

Abstract

backgroundThe mammalian target of rapamycin (mTOR) inhibitors are valuable immunosuppressants in clinical transplantation; however, the mTOR regulation of allogeneic T-cell responses is not fully understood yet. Therefore, the objective of this study is to investigate the effects of T-cell-specific mTOR deletion on the allogeneic T-cell responses and heart transplant survival.

methodsBALB/c heart allografts, with or without BALB/c skin sensitization, were transplanted in the wild-type C57BL/6, Mtor

resultsIn the absence of donor skin sensitization, long-term heart allograft survival was achieved in the Mtor

conclusionsmTOR is required for Tfh cell response in murine heart transplantation. T-cell-specific deletion of both mTOR and Stat3 abrogates the memory response to heart transplants. These findings help us to better understand the molecular mechanisms underlying the T cell immunity to transplanted organs.

Indexed as

Heart TransplantationImmunity, CellularAllograftsAnimalsDisease Models, AnimalGraft RejectionGraft SurvivalMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutT-Lymphocytes, Helper-InducerTOR Serine-Threonine KinasesTOR Serine-Threonine Kinasesallograft survivaleffector T cellheart transplantationmemory T cell responsemTORT follicular helper

Identifiers

PMID31831210
PMCPMC6981023
OpenAlexW2989758345

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.